Dexela
London
About Dexela
Dexela develops a 3-D breast imaging technology for the early detection of breast cancer. It offers DexTop Digital Mammography Workstation, a screening workstation that ensures screening workflow and performance; and Dexela 3D reconstruction engine that is offered to OEM partners as a software module with licensing terms. The company provides flat panel CMOS X-ray detectors that are used in various medical applications, including mammography and tomosynthesis, breast CT, dental CBCT, fluoroscopy, cardiology and angiographic imaging, and bone densitometry, as well as in scientific instrumentation and non-destructive testing applications. It also offers consulting services in the areas of digital tomosynthesis, mammography acquisition geometry, and optimal reconstruction of 3D data; and design and implementation resources for hardware and software engineering projects. Dexela Limited was incorporated in 2003 and is based in London, the United Kingdom. It has an X-ray research and development facility in Sudbury, Massachusetts.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 5,001 – 10,000
- Total funding: $2.3M
- Funding stage: M&A
- Last round: Series Unknown (Jan 2009)
- Website: dexela.com
- Phone: 44 20 7148 3107
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Canonical: https://fsome.com/organization/dexela-3237938 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.